Microsoft Word - Sun Pharma - Q2FY11 Results Review 02Nov10.doc - Accounting standard - Document - PDFSEARCH.IO

First Page		Document Content
Date: 2010-11-02 03:38:57 Financial ratios Business Fundamental analysis Valuation Income Earnings before interest taxes depreciation and amortization Net profit Times interest earned Cash flow statement Finance Accountancy Generally Accepted Accounting Principles		Microsoft Word - Sun Pharma - Q2FY11 Results Review 02Nov10.doc Add to Reading List Source URL: smartinvestor.business-standard.com Download Document from Source Website File Size: 241,51 KB Share Document on Facebook

	HIGHLIGHTS • Revenues in 3Q13 were 5,336 TUSD compared to last year’s launch quarter of The Secret World 10,963 TUSD for 3Q12. • Earnings before Interest, Tax, Depreciation and Amortization (EBITDA) for 3Q13 were DocID: 1umA3 - View Document
	Microsoft Word - ccwdnotes DocID: 1rugN - View Document
	Results for the Quarter Ended June 30, 2016 K-IFRS, Non-audited July 28th, 2016 DocID: 1ru8X - View Document
	Second Quarter 2004 Results FOR IMMEDIATE RELEASE Highlights ¾ Record second-quarter Consolidated and Television Broadcasting segment net sales, operating income before depreciation and amortization and margins DocID: 1rshF - View Document
	ANDRITZ financial report Q1 2011 DocID: 1rsgG - View Document